Latest News-3SBIO INC. Mediaroom_Page-PR Newswire APAC

3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2010 Results

2010 revenues grew 32.1% to RMB418.6 million (US$63.4 million) 2011 revenues expected to grow 20%...

2011-03-16 08:00 1113

3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results

SHENYANG, China, Feb. 19, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or ...

2011-02-21 07:20 761

3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP

SHENYANG, China, Jan. 25, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or ...

2011-01-25 09:00 791

3SBio Inc. Acquires Worldwide Rights to Pegsiticase From EnzymeRx

SHENYANG, China, Nov. 29, 2010 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company")...

2010-11-29 21:43 699

3SBio Inc. Announces Results of Annual General Meeting

SHENYANG, China, Nov. 23, 2010 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company")...

2010-11-24 12:16 930

3SBio Announces Conversion of Isotechnika Debenture

SHENYANG, China, Nov. 19, 2010 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a...

2010-11-19 01:30 773

3SBio Inc. Announces Unaudited Third Quarter Results

Third quarter revenues grew 24.9% year-over-year to RMB115.6 million (US$17.3 million); First nine m...

2010-11-16 09:00 593

3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results

SHENYANG, China, Oct. 18 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the C...

2010-10-18 17:14 1138

3SBio Inc. to Hold 2010 Annual General Meeting on October 29, 2010

SHENYANG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "...

2010-09-27 12:01 954

3SBio Announces Partial Conversion of Isotechnika Debenture

SHENYANG, China, Sept 14 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a ...

2010-09-15 09:02 1029

3SBio Announces Investor Conference Schedule

SHENYANG, China, Sept. 7 /PRNewswire-Asia/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading Chi...

2010-09-07 21:30 1189

3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China

SHENYANG, China, Aug. 24 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a lead...

2010-08-24 19:00 1112

3SBio Inc. Announces Unaudited Second Quarter Results

SHENYANG, China, Aug. 18 /PRNewswire-Asia-FirstCall/ -- -- Second quarter revenues grew 29.5...

2010-08-18 08:00 726

3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results

SHENYANG, China, Aug. 5 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or...

2010-08-06 11:57 927

3SBio Inc. Announces Filing of Form 20-F With SEC

SHENYANG, China, June 28 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio"...

2010-06-28 20:46 535

3SBio Inc. Announces Unaudited First Quarter 2010 Results

Net revenues grew 40.5% year-on-year to RMB96.4 million (US$14.1 million) Net income grew...

2010-05-17 23:20 663

3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010

SHENYANG, China, May 11 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Compan...

2010-05-11 17:38 504

3SBio Announces Changes to its Board of Directors

SHENYANG, China, March 10 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnolog...

2010-03-10 16:29 621

3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results

Company exceeds guidance with 2009 revenue of RMB316.9 million (US$46.4 million) Full-year 2009...

2010-02-12 09:00 736

3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial

SHENYANG, China, Feb. 12 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology...

2010-02-12 09:00 766